Nanoparticle Characterization and Drug Encapsulation: A New Perspective
Scientists in the United States have recently published findings on the characterization and drug encapsulation of solid lipid nanoparticles. The study, conducted by researchers at the University of North Carolina, reveals that careful characterization of these nanoparticles is essential for predicting their behavior in biological environments. The researchers used the nanotemplate engineering method to create nanoparticles containing an ester prodrug, which were then analyzed using various techniques to determine their size distribution and drug encapsulation efficiency.
Key Takeaways:
- The study found that the size distribution of the nanoparticles was uniform, with an average size of 93.2 ± 0.5 nm.
- However, gel filtration chromatography revealed two nanoparticle populations with different drug encapsulation efficiencies and surface properties.
- The first population of nanoparticles had a drug/lipid ratio of 0.04 and no human serum albumin (HSA) was adsorbed, while the second population had a ratio of 0.25 and minor amounts of HSA were adsorbed.
- After 24 hours incubation in 50% human plasma, 80% of the [(3)H]-dexamethasone palmitate was associated with the nanoparticles.
- The researchers noted that the characterization of solid lipid nanoparticles produced by this method may be challenging from a regulatory perspective.
Statistics:
- 93.2 nm: average size of the nanoparticles
- 97%: drug encapsulation efficiency
- 0.04: drug/lipid ratio of the first nanoparticle population
- 0.25: drug/lipid ratio of the second nanoparticle population
- 80%: percentage of [(3)H]-dexamethasone palmitate associated with the nanoparticles after 24 hours incubation
Sources:
- Acs Nano (Uniformity of drug payload and its effect on stability of solid lipid nanoparticles containing an ester prodrug. Acs Nano, 2011;5(1):209-16)
- Nanotechnology - Nanoparticles (no specific date or publication information)